These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 24218270)
41. Characterization of C3dg binding to a recess formed between short consensus repeats 1 and 2 of complement receptor type 2 (CR2; CD21). Prodinger WM; Schwendinger MG; Schoch J; Köchle M; Larcher C; Dierich MP J Immunol; 1998 Nov; 161(9):4604-10. PubMed ID: 9794388 [TBL] [Abstract][Full Text] [Related]
42. A comparative study of normal B cells and the EBV-positive Burkitt's lymphoma cell line, Raji, as activators of the complement system. Marquart HV; Olesen EH; Johnson AA; Damgaard G; Leslie RG Scand J Immunol; 1997 Sep; 46(3):246-53. PubMed ID: 9315112 [TBL] [Abstract][Full Text] [Related]
43. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3. Vik DP; Fearon DT J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185 [TBL] [Abstract][Full Text] [Related]
44. Expression of complement receptor 2 (CD21), membrane IgM and the inhibitory receptor CD32 (FcgammaRIIb) in the lymphoid tissues of neonatal calves. Chattha KS; Firth MA; Hodgins DC; Shewen PE Vet Immunol Immunopathol; 2010 Sep; 137(1-2):99-108. PubMed ID: 20488561 [TBL] [Abstract][Full Text] [Related]
45. Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21). Esparza I; Becherer JD; Alsenz J; De la Hera A; Lao Z; Tsoukas CD; Lambris JD Eur J Immunol; 1991 Nov; 21(11):2829-38. PubMed ID: 1834472 [TBL] [Abstract][Full Text] [Related]
46. Characterization of the EBV/C3d receptor on the human Jurkat T cell line: evidence for a novel transcript. Sinha SK; Todd SC; Hedrick JA; Speiser CL; Lambris JD; Tsoukas CD J Immunol; 1993 Jun; 150(12):5311-20. PubMed ID: 8390533 [TBL] [Abstract][Full Text] [Related]
47. Regulation of humoral immunity by complement. Carroll MC; Isenman DE Immunity; 2012 Aug; 37(2):199-207. PubMed ID: 22921118 [TBL] [Abstract][Full Text] [Related]
48. Murine complement receptor gene expression: Cr2 gene transcripts are depressed during a high dose microbial challenge. Tan SS; O'Toole EM; Kurtz CB; Weis JH Immunology; 1993 May; 79(1):82-8. PubMed ID: 8509145 [TBL] [Abstract][Full Text] [Related]
49. Expression in insect cells of the functional domain of CD21 (complement receptor type two) as a truncated soluble molecule using a baculovirus vector. Prodinger WM; Schoch J; Schwendinger MG; Hellwage J; Parson W; Zipfel PF; Dierich MP Immunopharmacology; 1997 Dec; 38(1-2):141-8. PubMed ID: 9476125 [TBL] [Abstract][Full Text] [Related]
50. Factor I-mediated processing of complement fragments on HIV immune complexes targets HIV to CR2-expressing B cells and facilitates B cell-mediated transmission of opsonized HIV to T cells. Bánki Z; Wilflingseder D; Ammann CG; Pruenster M; Müllauer B; Holländer K; Meyer M; Sprinzl GM; van Lunzen J; Stellbrink HJ; Dierich MP; Stoiber H J Immunol; 2006 Sep; 177(5):3469-76. PubMed ID: 16920989 [TBL] [Abstract][Full Text] [Related]
51. Uncoupling CD21 and CD19 of the B-cell coreceptor. Barrington RA; Schneider TJ; Pitcher LA; Mempel TR; Ma M; Barteneva NS; Carroll MC Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14490-5. PubMed ID: 19706534 [TBL] [Abstract][Full Text] [Related]
52. Revisiting the Coreceptor Function of Complement Receptor Type 2 (CR2, CD21); Coengagement With the B-Cell Receptor Inhibits the Activation, Proliferation, and Antibody Production of Human B Cells. Kovács KG; Mácsik-Valent B; Matkó J; Bajtay Z; Erdei A Front Immunol; 2021; 12():620427. PubMed ID: 33868238 [TBL] [Abstract][Full Text] [Related]
53. Cutting edge: members of the Staphylococcus aureus extracellular fibrinogen-binding protein family inhibit the interaction of C3d with complement receptor 2. Ricklin D; Ricklin-Lichtsteiner SK; Markiewski MM; Geisbrecht BV; Lambris JD J Immunol; 2008 Dec; 181(11):7463-7. PubMed ID: 19017934 [TBL] [Abstract][Full Text] [Related]
54. Spontaneous complement activation on human B cells results in localized membrane depolarization and the clustering of complement receptor type 2 and C3 fragments. Løbner M; Leslie RG; Prodinger WM; Nielsen CH Immunology; 2009 Sep; 128(1 Suppl):e661-9. PubMed ID: 19740327 [TBL] [Abstract][Full Text] [Related]
55. Deletion of putative intronic control sequences does not alter cell or stage specific expression of Cr2. Roundy KM; Weis JJ; Weis JH Mol Immunol; 2009 Dec; 47(2-3):517-25. PubMed ID: 19740539 [TBL] [Abstract][Full Text] [Related]
56. CR2+ marginal zone B cell production of pathogenic natural antibodies is C3 independent. Woods KM; Pope MR; Hoffman SM; Fleming SD J Immunol; 2011 Feb; 186(3):1755-62. PubMed ID: 21187447 [TBL] [Abstract][Full Text] [Related]
57. The solvent at antigen-binding site regulated C3d-CR2 interactions through the C-terminal tail of C3d at different ion strengths: insights from molecular dynamics simulation. Zhang Y; Guo J; Li L; Liu X; Yao X; Liu H Biochim Biophys Acta; 2016 Oct; 1860(10):2220-31. PubMed ID: 27154286 [TBL] [Abstract][Full Text] [Related]
58. Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3. Twohig J; Kulik L; Haluszczak C; Reuter J; Rossbach A; Bull M; Holers VM; Marchbank KJ Mol Immunol; 2007 Jul; 44(13):3434-44. PubMed ID: 17379312 [TBL] [Abstract][Full Text] [Related]
59. Identification and Characterization of chCR2, a Protein That Binds Chicken Complement Component 3d. Jin H; Kong Z; Jiang B; Tu M; Xu J; Cheng J; Liu W; Zhang Z; Li Y J Immunol; 2023 May; 210(9):1408-1418. PubMed ID: 36971659 [TBL] [Abstract][Full Text] [Related]
60. CR2 units of CR2 complexes are possibly associated with nucleophilic agents through reactive covalent links. Di Certo MG; Faggioni A; Barile G Cell Biol Int; 2003; 27(1):7-22. PubMed ID: 12713795 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]